Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep.

Slides:



Advertisements
Similar presentations
ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre
Advertisements

MALDI-TOF is not useful in the diagnosis of catheter colonization based on superficial cultures: results from an in vitro study María Guembe, María Jesús.
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Expression analysis of efflux pump genes among drug-susceptible and multidrug- resistant Mycobacterium tuberculosis clinical isolates and reference strains 
Performance of cobas® 4800 and m2000 real-time™ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and self-collected vaginal.
Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis  Bahadir Aslan, Mehmet Sami Serin, Gonul Aslan, Aydiner Kalaci, Ahmet Nedim.
Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV.
Serological diagnosis of Toxoplasma gondii infection
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Salvage therapy for multidrug-resistant tuberculosis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Personalized Disease Models on a Chip
Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection  Y.W.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B  W.-K. Seto, D. K.-H. Wong,
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
Surveillance of Legionnaires’ disease in Austria
Cryptococcus neoformans var
Vector control: a cornerstone in the malaria elimination campaign
Hepatitis C Virus Infection in the Older Patient
E.C. Böttger  Clinical Microbiology and Infection 
Tracking the naturally occurring mutations across the full-length genome of hepatitis B virus of genotype D in different phases of chronic e-antigen-negative.
Epidemiology of opportunistic infections in AIDS patients
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Salvage therapy for multidrug-resistant tuberculosis
Elements of design: the knowledge on which we build
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Personalized Disease Models on a Chip
Metagenomics and probiotics
Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals  H. von.
Hepatitis B and C virus-related carcinogenesis
A case of pleurisy associated with antibodies to Rickettsia conorii
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected.
T.M. File  Clinical Microbiology and Infection 
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Antimicrobial drug development – the past, the present, and the future
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Volume 17, Issue 2, Pages (February 1950)
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
The atypical pneumonias: clinical diagnosis and importance
Chronic hepatitis B in children and adolescents
Evaluation of diagnostic tests
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Update on invasive aspergillosis: clinical and diagnostic aspects
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients  D. He, S. Guo, P. Zhu, S. Tao, M. Li,
Presentation transcript:

Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method  Sevgi Ciftci, Fahriye Keskin, Aris Cakiris, Filiz Akyuz, Binnur Pinarbasi, Neslihan Abaci, Erdinc Dincer, Selim Badur, Sabahattin Kaymakoglu, Duran Ustek  Diagnostic Microbiology and Infectious Disease  Volume 79, Issue 1, Pages 25-30 (May 2014) DOI: 10.1016/j.diagmicrobio.2014.01.005 Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig. 1 Potential resistance mutations in HBeAg-positive and HBeAg-negative patients. Diagnostic Microbiology and Infectious Disease 2014 79, 25-30DOI: (10.1016/j.diagmicrobio.2014.01.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.